PT-141
libido compound
PT-141 is a potent synthetic melanocortin receptor agonist engineered to address sexual dysfunction through direct central nervous system modulation. It facilitates arousal by selectively activating neural pathways associated with desire and physiological responsiveness.
Research Areas
Mechanism of Action
PT-141 acts as a non-selective melanocortin receptor agonist that primarily targets the MC4R subtype within the hypothalamus to stimulate sexual motivation and arousal.
Biological Pathways
Areas of Research Interest
Potential effects under study. Not all are established in humans.
- •Increases sexual desire
- •Promotes physiological arousal
- •Enhances dopaminergic signaling
- •Activates central melanocortinergic pathways
Risks & Cautions
This is a relative educational classification, not a determination of safety. Effects, adverse events and long-term data may be incomplete. Speak with a licensed healthcare professional about any individual decision.
Evidence & Research References
Research references are being reviewed for this entry.
STACKWELL classification: Moderate Evidence. Classifications are editorial and are never influenced by commercial relationships.
Frequently Asked Questions
Community Discussion
Questions and experiences from members. Community posts are anecdotes, not clinical evidence.
Discuss PT-141Educational content only. STACKWELL summarizes published research and does not provide individualized medical advice. Some compounds discussed may be investigational or not approved for human use in your jurisdiction. STACKWELL does not recommend, prescribe or dose any compound, and this content is not a substitute for care from a qualified healthcare professional.